This case involves a postmenopausal, 55-year-old woman with a node-negative cancer considered to be a medullary carcinoma. The tumor is ER- and PR-positive and poorly differentiated (grade 3). She has ...
Patients eligible for this multicenter, phase II trial had metastatic poorly differentiated neuroendocrine carcinoma and had received no previous treatment. Patients with a variety of known primary ...
Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results